Ashwagandha for Anxiety

N/A

Recruiting

Research Sponsored by SF Research Institute, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults (male and female) aged between 18 and 65 years

Be older than 18 years old

Must not have

Patients with known clinically significant acute unstable hepatic, renal, cardiovascular, or respiratory disease that will prevent participation in the study

Patients receiving any of the medications known to affect stress and anxiety (corticosteroids, antidepressants, antipsychotics, mood stabilizers, and anti-epileptic medications) during 4 weeks prior to screening

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pss assessment will be done at visit 1 (screening visit/ enrolment visit/ baseline visit- day 1), visit 2 (week 4), and visit 3 (week 8).

Summary

"This trial is testing the effectiveness and safety of a special blend of Ashwagandha root extract for adults with high stress and anxiety. Participants will be randomly assigned to one of three groups and will

Who is the study for?

Adult men and women experiencing high levels of stress and anxiety can join this trial. They must understand the study's purpose, agree to take capsules twice daily for 8 weeks, and sign a consent form. Specific details on who can't participate are not provided.

What is being tested?

The trial is testing the effectiveness of two forms of Ashwagandha root extract against a placebo in reducing stress and anxiety over an 8-week period. Participants will be randomly assigned to one of three groups: proprietary blend, KSM-66 extract, or placebo.

What are the potential side effects?

Potential side effects are not detailed here but typically could include digestive discomfort or allergic reactions given that Ashwagandha is an herbal supplement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have severe liver, kidney, heart, or lung problems that would stop me from joining the study.

Select...

I have not taken medication for stress, anxiety, or mood disorders in the last 4 weeks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pss assessment will be done at visit 1 (screening visit/ enrolment visit/ baseline visit- day 1), visit 2 (week 4), and visit 3 (week 8).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pss assessment will be done at visit 1 (screening visit/ enrolment visit/ baseline visit- day 1), visit 2 (week 4), and visit 3 (week 8).

This trial's timeline: 3 weeks for screening, Varies for treatment, and pss assessment will be done at visit 1 (screening visit/ enrolment visit/ baseline visit- day 1), visit 2 (week 4), and visit 3 (week 8). for reporting.